Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.
RBC Capital Maintains Outperform on Bausch & Lomb, Raises Price Target to $20
RBC Capital analyst Douglas Miehm maintains Bausch & Lomb (NYSE:BLCO) with a Outperform and raises the price target from $17 to $20.
Bausch + Lomb Introduces Enhanced PreserVision AREDS 2 Formula Mini Soft Gels With OCUSorb
Bausch + Lomb Corporation (TSX:BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of
Benzinga’s Top Ratings Upgrades, Downgrades For December 21, 2022
Upgrades For PagSeguro Digital Ltd (NYSE:PAGS), New Street Research upgraded the previous rating of Neutral to Buy. In…
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO).
What 7 Analyst Ratings Have To Say About Bausch & Lomb
Analysts have provided the following ratings for Bausch & Lomb (NYSE:BLCO) within the last quarter: Bullish Somewhat Bullish…
RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $17
RBC Capital analyst Douglas Miehm maintains Bausch & Lomb (NYSE:BLCO) with a Outperform and lowers the price target from $18 to $17.
What 4 Analyst Ratings Have To Say About Bausch & Lomb
Analysts have provided the following ratings for Bausch & Lomb (NYSE:BLCO) within the last quarter:
What 4 Analyst Ratings Have To Say About Bausch & Lomb
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: